Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study
出版年份 2021 全文链接
标题
Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study
作者
关键词
-
出版物
LANCET INFECTIOUS DISEASES
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-04-15
DOI
10.1016/s1473-3099(21)00142-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Detection of mutations associated with artemisinin resistance at k13-propeller gene and a near complete return of chloroquine susceptible falciparum malaria in Southeast of Tanzania
- (2020) George M. Bwire et al. Scientific Reports
- Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda
- (2020) Aline Uwimana et al. NATURE MEDICINE
- Efficacy of artemether–lumefantrine versus dihydroartemisinin–piperaquine for the treatment of uncomplicated malaria among children in Rwanda: an open-label, randomized controlled trial
- (2019) Aline Uwimana et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Artemisinin Resistance–Associated K13 Polymorphisms of Plasmodium falciparum in Southern Rwanda, 2010–2015
- (2016) Costanza Tacoli et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Robust Algorithm for Systematic Classification of Malaria Late Treatment Failures as Recrudescence or Reinfection Using Microsatellite Genotyping
- (2015) Mateusz M. Plucinski et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Independent Emergence of thePlasmodium falciparumKelch Propeller Domain Mutant Allele C580Y in Guyana
- (2015) Stella M. Chenet et al. JOURNAL OF INFECTIOUS DISEASES
- Genetic Analysis and Species Specific Amplification of the Artemisinin Resistance-Associated Kelch Propeller Domain in P. falciparum and P. vivax
- (2015) Eldin Talundzic et al. PLoS One
- Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors That Affect Treatment Outcomes for P. falciparum Malaria After Artemether-Lumefantrine and Artesunate-Amodiaquine
- (2014) Meera Venkatesan et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
- (2013) Frédéric Ariey et al. NATURE
- Reduced Susceptibility of Plasmodium falciparum to Artesunate in Southern Myanmar
- (2013) Myat P. Kyaw et al. PLoS One
- Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study
- (2012) Aung Pyae Phyo et al. LANCET
- Molecular epidemiology of drug resistance markers of Plasmodium falciparum in Yunnan Province, China
- (2012) Fang Huang et al. MALARIA JOURNAL
- Molecular markers of Plasmodium falciparum drug resistance in southern highland Rwanda
- (2011) Irene Zeile et al. ACTA TROPICA
- Multiple Genetic Backgrounds of the AmplifiedPlasmodium falciparumMultidrug Resistance (pfmdr1) Gene and Selective Sweep of 184F Mutation in Cambodia
- (2010) Sumiti Vinayak et al. JOURNAL OF INFECTIOUS DISEASES
- In Vivo Parasitological Measures of Artemisinin Susceptibility
- (2010) Kasia Stepniewska et al. JOURNAL OF INFECTIOUS DISEASES
- Origin and Evolution of Sulfadoxine Resistant Plasmodium falciparum
- (2010) Sumiti Vinayak et al. PLoS Pathogens
- Artemisinin Resistance inPlasmodium falciparumMalaria
- (2009) Arjen M. Dondorp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hitchhiking and Selective Sweeps of Plasmodium falciparum Sulfadoxine and Pyrimethamine Resistance Alleles in a Population from Central Africa
- (2008) A. M. McCollum et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evidence of Artemisinin-Resistant Malaria in Western Cambodia
- (2008) Harald Noedl et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started